PortfoliosLab logo
Intuitive Surgical, Inc. (ISRG)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US46120E6023

CUSIP

46120E602

IPO Date

Jun 13, 2000

Highlights

Market Cap

$199.19B

EPS (TTM)

$6.79

PE Ratio

81.35

PEG Ratio

3.90

Total Revenue (TTM)

$8.71B

Gross Profit (TTM)

$5.85B

EBITDA (TTM)

$2.95B

Year Range

$397.47 - $616.00

Target Price

$575.78

Short %

1.36%

Short Ratio

2.69

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

S&P 500

Returns By Period

Intuitive Surgical, Inc. (ISRG) returned 5.82% year-to-date (YTD) and 37.36% over the past 12 months. Over the past 10 years, ISRG delivered an annualized return of 25.84%, outperforming the S&P 500 benchmark at 10.85%.


ISRG

YTD

5.82%

1M

6.80%

6M

1.91%

1Y

37.36%

3Y*

34.38%

5Y*

23.36%

10Y*

25.84%

^GSPC (Benchmark)

YTD

0.51%

1M

5.49%

6M

-2.00%

1Y

12.02%

3Y*

12.68%

5Y*

14.19%

10Y*

10.85%

*Annualized

Monthly Returns

The table below presents the monthly returns of ISRG, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20259.56%0.22%-13.59%4.15%7.08%5.82%
202412.11%1.95%3.50%-7.13%8.50%10.63%-0.05%10.80%-0.28%2.56%7.57%-3.70%54.72%
2023-7.41%-6.63%11.37%17.91%2.20%11.08%-5.13%-3.61%-6.52%-10.29%18.54%8.53%27.14%
2022-20.91%2.16%3.91%-20.68%-4.87%-11.83%14.68%-10.61%-8.89%31.49%9.71%-1.86%-26.15%
2021-8.61%-1.45%0.29%17.06%-2.64%9.20%7.81%6.26%-5.64%8.98%-10.19%10.78%31.76%
2020-5.31%-4.61%-7.26%3.16%13.54%-1.76%20.29%6.62%-2.91%-5.98%8.84%12.68%38.39%
20199.34%4.58%4.19%-10.51%-8.97%12.84%-0.96%-1.57%5.59%2.41%7.22%-0.30%23.43%
201818.29%-1.21%-3.19%6.77%4.29%4.09%6.21%10.20%2.50%-9.20%1.86%-9.79%31.23%
20179.23%6.40%4.00%9.05%9.43%2.26%0.31%7.08%4.10%7.67%6.51%-8.71%72.64%
2016-0.97%4.11%6.75%4.21%1.33%4.21%5.19%-1.34%5.60%-7.28%-4.22%-1.49%16.11%
2015-6.51%1.12%1.01%-1.79%-1.66%-0.67%10.05%-4.17%-10.05%8.06%4.72%5.03%3.26%
20146.12%9.14%-1.54%-17.42%2.22%11.38%11.11%2.72%-1.74%7.36%4.43%2.16%37.72%
Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 84, ISRG is among the top 16% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of ISRG is 8484
Overall Rank
The Sharpe Ratio Rank of ISRG is 8484
Sharpe Ratio Rank
The Sortino Ratio Rank of ISRG is 8282
Sortino Ratio Rank
The Omega Ratio Rank of ISRG is 8282
Omega Ratio Rank
The Calmar Ratio Rank of ISRG is 8888
Calmar Ratio Rank
The Martin Ratio Rank of ISRG is 8484
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Intuitive Surgical, Inc. (ISRG) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Intuitive Surgical, Inc. Sharpe ratios as of Jun 1, 2025 (values are recalculated daily):

  • 1-Year: 1.10
  • 5-Year: 0.70
  • 10-Year: 0.82
  • All Time: 0.52

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Intuitive Surgical, Inc. compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

Dividend History


Intuitive Surgical, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Intuitive Surgical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Intuitive Surgical, Inc. was 82.25%, occurring on Apr 11, 2001. Recovery took 927 trading sessions.

The current Intuitive Surgical, Inc. drawdown is 9.52%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-82.25%Aug 1, 2000176Apr 11, 2001927Dec 21, 20041103
-75.89%Apr 11, 2008224Mar 2, 2009251Mar 1, 2010475
-49.9%Nov 9, 2021235Oct 14, 2022315Jan 18, 2024550
-40.52%Feb 21, 202022Mar 23, 202081Jul 17, 2020103
-40.11%May 2, 2012507May 8, 2014465Mar 14, 2016972
Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Intuitive Surgical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Intuitive Surgical, Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 4.4% positive surprise.


0.000.501.001.502.0020212022202320242025
1.81
1.73
Actual
Estimate

Valuation

The Valuation section provides an overview of how Intuitive Surgical, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for ISRG, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, ISRG has a P/E ratio of 81.3. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for ISRG compared to other companies in the Medical Instruments & Supplies industry. ISRG currently has a PEG ratio of 3.9. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ISRG relative to other companies in the Medical Instruments & Supplies industry. Currently, ISRG has a P/S ratio of 22.9. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for ISRG in comparison with other companies in the Medical Instruments & Supplies industry. Currently, ISRG has a P/B value of 11.6. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items